Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Adc Therapeutics Sa (ADCT)

Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adc Therapeutics Sa BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 CHE

www.adctherapeutics.com Employees: 274 P: 41-21-653-0200

Description:

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.

Key Statistics

Overview:

Market Capitalization, $K 189,512
Enterprise Value, $K 23,642
Shares Outstanding, K 96,690
Annual Sales, $ 69,560 K
Annual Net Income, $ -240,050 K
Last Quarter Sales, $ 18,460 K
Last Quarter Net Income, $ -43,970 K
EBIT, $ -135,430 K
EBITDA, $ -132,160 K
60-Month Beta 1.52
% of Insider Shareholders 4.10%
% of Institutional Shareholders 41.10%
Float, K 92,726
% Float 95.90%
Short Volume Ratio 0.65

Growth:

1-Year Return 53.13%
3-Year Return -90.78%
5-Year Return 0.00%
5-Year Revenue Growth 6,001.75%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm -2.39
EPS Growth vs. Prev Qtr -10.53%
EPS Growth vs. Prev Year 27.59%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ADCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -61.33%
Profit Margin % -345.10%
Debt/Equity -0.66
Price/Sales 2.72
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.78
Interest Coverage -3.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar